The medication should feel cool to the touch, not cold, and absolutely never frozen
Our objective is to present the pharmacological mechanisms, safety profiles, and regulatory status of prominent approved and unapproved peptides marketed direct to patients, including AOD-9604 (anti-obesity drug 9604), BPC-157 (body protection compound 157), CJC-1295, FS-344 (follistatin-344), GHK-Cu (glycyl-l-histidyl-l-lysine copper), ipamorelin, MOTS-C (mitochondrial ORF of the 12S rRNA type-c), sermorelin, SS-31 (elamipretide), tesamorelin (Egrifta), T4 (thymosin beta-4), and TB-500 (thymosin beta-4 fragment)
Cignarella F, Cantoni C, Ghezzi L, Salter A, Dorsett Y, Chen L et al (2018) Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota
They received MHRA approval on 11 June 2026 and are expected to be available by private prescription within weeks
Antihyperlgycemic effects of short term resveratrol supplementation in type 2 diabetic patients
Provides Individual Support "If you want to go fast, go solo